指南与共识肾移植

KDOQI对美国2020 KDIGO肾移植候选者评估与管理临床实践指南的解读

KDOQI US Commentary on the 2020 KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation.
指南 / 共识 · Am J Kidney Dis · 2021-03-18

该文是NKF-KDOQI工作组对美国2020 KDIGO肾移植候选者评估与管理指南的评论。工作组选取关键主题,总结KDIGO推荐并评论其临床实用性和实施挑战。总体上工作组认同KDIGO推荐,但指出高质量证据缺乏带来的决策挑战及平衡公平与效用的问题。

要点

  • KDIGO指南基于截至2019年5月的文献,由国际专家组制定。
  • KDOQI工作组广泛认同KDIGO推荐,但强调证据质量不足。
  • 决策需平衡移植获益、手术风险与长期免疫抑制风险。

核心结论

  • KDOQI工作组广泛认同2020 KDIGO肾移植候选者评估与管理指南的推荐,但指出高质量证据缺乏和需平衡公平与效用。

研究设计与样本

  • 该文为NKF-KDOQI convened的美国移植肾内科医生工作组对2020 KDIGO指南的评论,指南基于截至2019年5月的文献综述制定。

主要发现

  • 移植中心在候选者评估和决策方法上存在相当大差异。
  • KDIGO指南涵盖广泛主题,提供实践推荐作为移植专业人员参考。
  • KDOQI评论每节总结关键KDIGO推荐并评论其临床实用性和实施挑战。

关键数值与推荐

  • KDIGO指南由国际移植和肾脏病专家通过截至2019年5月的文献综述制定。

临床怎么用

  • 临床可参考KDIGO推荐进行肾移植候选者评估与管理,但需注意证据局限并平衡公平与效用。

局限性

  • 缺乏高质量证据,决策需平衡公平与效用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Evaluation of patients for kidney transplant candidacy is a comprehensive process that involves a detailed assessment of medical and surgical issues, psychosocial factors, and patients' physical and cognitive abilities with an aim of balancing the benefits of transplantation and potential risks of surgery and long-term immunosuppression. There is considerable variability among transplant centers in their approach to evaluation and decision-making regarding transplant candidacy. The 2020 KDIGO (Kidney Disease: Improving Guidelines Outcome) clinical practice guideline on the evaluation and management of candidates for kidney transplantation provides practice recommendations that can serve as a useful reference guide to transplant professionals. The guideline, covering a broad range of topics, was developed by an international group of experts from transplant and nephrology through a review of literature published until May 2019. A work group of US transplant nephrologists convened by NKF-KDOQI (National Kidney Foundation-Kidney Disease Quality Initiative) chose key topics for this commentary with a goal of presenting a broad discussion to the US transplant community. Each section of this article has a summary of the key KDIGO guideline recommendations, followed by a brief commentary on the recommendations, their clinical utility, and potential implementation challenges. The KDOQI work group agrees broadly with the KDIGO recommendations but also recognizes and highlights the decision-making challenges that arise from lack of high-quality evidence and the need to balance equity with utility of organ transplantation.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Puttarajappa CM, Schinstock CA, Wu CM, et al. KDOQI US Commentary on the 2020 KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. Am J Kidney Dis. 2021. PMID: 33745779. doi:10.1053/j.ajkd.2020.11.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。